Funded Projects
Explore our currently funded projects. You may search with all three fields, then focus your results by applying any of the dropdown filters. After customizing your search, you may download results and even save your specific search for later.
Project # | Project Title | Research Focus Area | Research Program | Administering IC | Institution(s) | Investigator(s) | Location(s) | Year Awarded |
---|---|---|---|---|---|---|---|---|
1OT2DA062972-01
Show Summary |
Increasing the Capacity of a Community-Based Research Center to Address Opioid Use Disorder and Related Health Inequities in Urban American Indian Communities | Translation of Research to Practice for the Treatment of Opioid Addiction | Native Collective Research Effort to Enhance Wellness (N CREW) Program: Addressing Overdose, Substance Use, Mental Health, and Pain | NIDA | NATIVE AMERICAN COMMUNITY CLINIC | STATELY, ANTONY | Minneapolis, MN | 2024 |
NOFO Title: HEAL Initiative: Native Collective Research Effort to Enhance Wellness (N CREW) Program - Addressing Overdose, Substance Use, Mental Health, and Pain (OT2)
NOFO Number: OTA-23-007 |
||||||||
1R01DA058640-01A1
Show Summary |
Improving Perioperative Care for Patients with Opioid Use Disorder | New Strategies to Prevent and Treat Opioid Addiction | NIDA | UNIVERSITY OF MICHIGAN | BICKET, MARK (contact); WALJEE, JENNIFER FILIP | Ann Arbor, MI | 2024 | |
NOFO Title: Research Project Grant (Parent R01 Clinical Trial Required)
NOFO Number: PA-20-183 |
||||||||
3UG1DA050072-05S1
Show Summary |
TCN PATHS Supplemental funding | Translation of Research to Practice for the Treatment of Opioid Addiction | Justice Community Overdose Innovation Network (JCOIN) | NIDA | YALE UNIVERSITY | WANG, EMILY AI-HUA | New Haven, CT | 2024 |
NOFO Title: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
NOFO Number: PA-20-272 |
||||||||
3R01DA057668-01S1
Show Summary |
Enhancing Precision in Overdose Mortality Prediction through Data Linkage: A Heterogeneous Capture-Recapture Approach to Estimating Opioid Use Disorder Prevalence in Ohio | Cross-Cutting Research | Leveraging Existing and Real-Time Opioid and Pain Management Data | NIDA | OHIO STATE UNIVERSITY | FERNANDEZ, SOLEDAD A (contact); FAREED, NALEEF | Columbus, OH | 2024 |
NOFO Title: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
NOFO Number: PA-20-272 |
||||||||
1R43DA058603-01A1
Show Summary |
Developing a novel epigenetic regulator as a treatment for opioid use disorder | Cross-Cutting Research | Small Business Programs | NIDA | EPIVARIO, LLC | KIM, THOMAS | Philadelphia, PA | 2024 |
NOFO Title: PHS 2022-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
NOFO Number: PA-22-176 |
||||||||
3U01DA055355-04S1
Show Summary |
9/24- Healthy Brain and Child Development National Consortium | Training the Next Generation of Researchers in HEAL | NIDA | NORTHWESTERN UNIVERSITY CHICAGO | WAKSCHLAG, LAUREN S (contact); NORTON, ELIZABETH SPENCER | Chicago, IL | 2024 | |
NOFO Title: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed)
NOFO Number: PA-23-189 |
||||||||
4UH3DA054825-03
Show Summary |
A novel and highly selective orexin 1 receptor antagonist for the treatment of patients with opioid use disorder. | Novel Therapeutic Options for Opioid Use Disorder and Overdose | Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose | NIDA | ASTRAZENECA PHARMACEUTICALS, LP | GURRELL, IAN | Wilmington, DE | 2024 |
NOFO Title: Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trial Optional)
NOFO Number: PAR-20-092 |
||||||||
1U01DA059994-01
Show Summary |
Efficacy, safety, and pharmacokinetic study of BICX104 naltrexone subcutaneous implant alone and in combination with bupropion for the treatment of Methamphetamine Use Disorder (MUD). | Novel Therapeutic Options for Opioid Use Disorder and Overdose | Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose | NIDA | BIOCORRX PHARMACEUTICALS, INC. | DEVARNEY, KATE BEEBE | Anaheim, CA | 2024 |
NOFO Title: Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)
NOFO Number: PAR-22-202 |
||||||||
1K01DA061078-01
Show Summary |
Reducing opioid misuse among urban Indigenous young adults in Montana using a culturally centered intervention | Training the Next Generation of Researchers in HEAL | NIDA | UNIVERSITY OF MONTANA | CHASE-BEGAY, DAMIAN M | Missoula, MT | 2024 | |
NOFO Title: HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K01 - Clinical Trial Required)
NOFO Number: PAS-22-206 |
||||||||
4UH3DA050325-03
Show Summary |
Use of a GLP-1 Agonist to Treat Opioid Use Disorder in Rats and Man | Novel Therapeutic Options for Opioid Use Disorder and Overdose | Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose | NIDA | PENN STATE HEALTH HERSHEY MEDICAL CENTER | GRIGSON, PATRICIA SUE (contact); BRICK, TIMOTHY R; BUNCE, SCOTT C; NYLAND, JENNIFER E | Hershey, PA | 2024 |
NOFO Title: Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trials Optional)
NOFO Number: RFA-DA-19-002 |
||||||||
4R33DA057600-02
Show Summary |
Using data to drive action to reduce opioid overdoses in Seattle, WA | Cross-Cutting Research | HEAL Data2Action (HD2A) | NIDA | UNIVERSITY OF WASHINGTON | BANTA-GREEN, CALEB (contact); HOOD, JULIA ELIZABETH | Seattle, WA | 2024 |
NOFO Title: HEAL Initiative: HEAL Data2Action Innovation Projects (R61/R33 Clinical Trial Optional)
NOFO Number: RFA-DA-22-051 |
||||||||
1R61DA059893-01A1
Show Summary |
Staffing and Supports for Implementing Cross-System Interventions with Peer Mentors | Translation of Research to Practice for the Treatment of Opioid Addiction | Optimizing the Quality, Reach, and Impact of Addiction Services | NIDA | OHIO STATE UNIVERSITY | BUNGER, ALICIA C (contact); SALDANA, LISA | Columbus, OH | 2024 |
NOFO Title: HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional)
NOFO Number: RFA-DA-23-053 |
||||||||
1R61DA062335-01
Show Summary |
Families left behind: Addressing prolonged grief and substance use disorders among people bereaved by drug overdose deaths | Translation of Research to Practice for the Treatment of Opioid Addiction | Optimizing the Quality, Reach, and Impact of Addiction Services | NIDA | STANFORD UNIVERSITY | OSILLA, KAREN CHAN (contact); ATHEY, ALISON | Standford, CA | 2024 |
NOFO Title: HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional)
NOFO Number: RFA-DA-23-053 |
||||||||
1R24DA061190-01
Show Summary |
PRIDE-CARES Center: Patient-Responsive Initiatives for Diverse Engagement - LGBTQ+ Community Action in Research to Eliminate Substance Use Disorder | Translation of Research to Practice for the Treatment of Opioid Addiction | NIDA | UNIVERSITY OF SOUTH CAROLINA | NATAFGI, NABIL M (contact); FIVECOAT, JAIME ERIN; KENNEDY, ANN BLAIR | Columbia, SC | 2024 | |
NOFO Title: Patient Engagement Resource Centers to Inform SUD Treatment Services Research (R24 Clinical Trial Optional)
NOFO Number: RFA-DA-24-016 |
||||||||
1R21DA061784-01
Show Summary |
Preclinical Trial: Targeting the Neuropeptide S Receptor to Curb Opioid Taking and Seeking | Novel Therapeutic Options for Opioid Use Disorder and Overdose | Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose | NIDA | STATE UNIVERSITY OF NEW YORK AT BUFFALO | CLARK, STEWART DONALDSON | Amherst, NY | 2024 |
NOFO Title: HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R21 Clinical Trial Not Allowed)
NOFO Number: RFA-DA-24-064 |
||||||||
1UG3DA062088-01
Show Summary |
Evaluation of psilocybin as an adjunctive treatment for opioid use disorder in methadone-maintained patients who continue to use illicit opioids | Novel Therapeutic Options for Opioid Use Disorder and Overdose | Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose | NIDA | NEW YORK UNIVERSITY SCHOOL OF MEDICINE | BOGENSCHUTZ, MICHAEL PARKS | New York, NY | 2024 |
NOFO Title: Psychedelics Treatment Research in Substance Use Disorder (UG3/UH3 Clinical Trials Optional)
NOFO Number: RFA-DA-25-058 |
||||||||
4U01HL150568-02
Show Summary |
Effects of experimental sleep disruption and fragmentation on cerebral Mu-opioid receptor function, Mu-opioid receptor agonist analgesia, and abuse liability | New Strategies to Prevent and Treat Opioid Addiction | Sleep Dysfunction as a Core Feature of Opioid Use Disorder and Recovery | NHLBI | JOHNS HOPKINS UNIVERSITY | SMITH, MICHAEL T | Baltimore, MD | 2024 |
NOFO Title: HEAL Initiative: Sleep and Circadian-Dependent Mechanisms Contributing to Opiate Use Disorder (OUD) and Response to Medication Assisted Treatment (MAT) (U01 Clinical Trial Optional)
NOFO Number: RFA-HL-19-029 |
||||||||
1R21DA060111-01
Show Summary |
The potential benefits of autophagy activator TFEB in opioid use disorder in mice | Novel Therapeutic Options for Opioid Use Disorder and Overdose | NIDA | FLORIDA INTERNATIONAL UNIVERSITY | LAKSHMANA, MADEPALLI KRISHNAPPA | Miami, FL | 2024 | |
NOFO Title: Emergency Awards: HEAL Initiative-Early-Stage Discovery of New Pain and Opioid Use Disorder Targets Within the Understudied Druggable Proteome (R21 Clinical Trial Not Allowed)
NOFO Number: RFA-TR-23-010 |
||||||||
3OT2OD037643-01S1
Show Summary |
All of Us Research Program New York Consortium | New Strategies to Prevent and Treat Opioid Addiction | OD | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | KRAFT, MONICA (contact); HOROWITZ, CAROL R; NADKARNI, GIRISH NITIN; SHROFF, NANDINI; SHUMAN, SASKIA | New York, NY | 2024 | |
NOFO Title: All of Us Engagement, Communications, and Enrollment Partnerships
NOFO Number: OTA-22-006 |
||||||||
1OT2DA061138-01
Show Summary |
Commitment to Recovery: Alaska Native Community Needs for Substance Use Treatment | Translation of Research to Practice for the Treatment of Opioid Addiction | Native Collective Research Effort to Enhance Wellness (N CREW) Program: Addressing Overdose, Substance Use, Mental Health, and Pain | NIDA | SOUTHCENTRAL FOUNDATION | SHANE, ALIASSA (contact); MICHLIG, GEORGIA J; TRINIDAD, SUSAN BROWN | Anchorage, AK | 2024 |
NOFO Title: HEAL Initiative: Native Collective Research Effort to Enhance Wellness (N CREW) Program - Addressing Overdose, Substance Use, Mental Health, and Pain (OT2)
NOFO Number: OTA-23-007 |
||||||||
1OT2DA061145-01
Show Summary |
Northwest Regional Research Center | Translation of Research to Practice for the Treatment of Opioid Addiction | Native Collective Research Effort to Enhance Wellness (N CREW) Program: Addressing Overdose, Substance Use, Mental Health, and Pain | NIDA | NORTHWEST PORTLAND AREA INDIAN HEALTH BOARD | TOWN, MATTHEW ALAN | Portland, OR | 2024 |
NOFO Title: HEAL Initiative: Native Collective Research Effort to Enhance Wellness (N CREW) Program - Addressing Overdose, Substance Use, Mental Health, and Pain Native Research Resource Network (OT2)
NOFO Number: OTA-23-008 |
||||||||
1R01DA059640-01A1
Show Summary |
Craving-based Digital Phenotyping During MOUD Treatment | New Strategies to Prevent and Treat Opioid Addiction | NIDA | UMASS CHAN MEDICAL SCHOOL | CARREIRO, STEPHANIE P | Worcester, MA | 2024 | |
NOFO Title: NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
NOFO Number: PA-20-185 |
||||||||
3UG1DA015831-23S2
Show Summary |
CTN145: Standard versus High Dose ED-Initiated Buprenorphine Induction Administrative Supplement 1 | New Strategies to Prevent and Treat Opioid Addiction | Optimizing the Quality, Reach, and Impact of Addiction Services | NIDA | YALE UNIVERSITY | D'ONOFRIO, GAIL (contact); HAWK, KATHRYN; HERRING, ANDREW | New Haven, CT | 2024 |
NOFO Title: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
NOFO Number: PA-20-272 |
||||||||
3UG1DA015831-23S1
Show Summary |
EMS initiated Buprenorphine for Opioid Use Disorder | Translation of Research to Practice for the Treatment of Opioid Addiction | Enhancing the National Drug Abuse Treatment Clinical Trials Network to Address Opioids | NIDA | YALE UNIVERSITY | D'ONOFRIO, GAIL (contact); CARROLL, GERARD; HSER, YIH-ING; KEATING, ELIZABETH | New Haven, CT | 2024 |
NOFO Title: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
NOFO Number: PA-20-272 |
||||||||
3U01DA055363-04S1
Show Summary |
The Transgenerational Influence of Discrimination on Mental Health | Training the Next Generation of Researchers in HEAL | NIDA | OREGON HEALTH & SCIENCE UNIVERSITY | SULLIVAN, ELINOR L (contact); GRAHAM, ALICE M | Portland, OR | 2024 | |
NOFO Title: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed)
NOFO Number: PA-23-189 |